These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23953888)

  • 1. Comparative pharmacokinetic profiles of a novel isotretinoin formulation (isotretinoin-Lidose) and the innovator isotretinoin formulation: a randomized, 4-treatment, crossover study.
    Webster GF; Leyden JJ; Gross JA
    J Am Acad Dermatol; 2013 Nov; 69(5):762-767. PubMed ID: 23953888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving bioavailability with a novel isotretinoin formulation (isotretinoin-Lidose).
    Tan J; Knezevic S
    Skin Therapy Lett; 2013; 18(6):1-3. PubMed ID: 24305729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Pharmacokinetic Profiles of a Novel Low-dose Micronized-isotretinoin 32 mg Formulation and Lidose-isotretinoin 40 mg in Fed and Fasted Conditions: Two Open-label, Randomized, Crossover Studies in Healthy Adult Participants.
    Madan S; Kumar S; Segal J
    Acta Derm Venereol; 2020 Feb; 100(4):adv00049. PubMed ID: 31774544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing Bioavailability: Advances in Oral Isotretinoin Formulations.
    Michael K; Tan J
    Skin Therapy Lett; 2024 Sep; 29(5):10-12. PubMed ID: 39353206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARTICLE: Advances in Oral Isotretinoin Therapy.
    Jones M; Armstrong AW; Baldwin H; Stein Gold L; Kircik LH
    J Drugs Dermatol; 2021 May; 20(5):s5-s11. PubMed ID: 33938693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne.
    Webster GF; Leyden JJ; Gross JA
    J Drugs Dermatol; 2014 Jun; 13(6):665-70. PubMed ID: 24918555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Lidose hard capsule formulation of fenofibrate is suprabioavailable compared to the nanoparticle tablet formulation under high-fat fed conditions.
    Verbeeck RK; De Niet S; Lebrun S; Tremege M; Rennie TW; Coffiner M; Streel B; Cahay B
    J Pharm Pharm Sci; 2015; 18(1):61-7. PubMed ID: 25877442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose pharmacokinetics of 2 or 3 tablets of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) under fed and fasted conditions: two randomized open-label trials.
    Devarakonda K; Kostenbader K; Giuliani MJ; Young JL
    BMC Pharmacol Toxicol; 2015 Nov; 16():31. PubMed ID: 26614499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isotretinoin conundrum: a randomized, openlabel, crossover study in Mexico to evaluate the bioavailability and bioequivalence of three pharmaceutical preparations of isotretinoin in healthy participants.
    Piñeyro-Garza E; Gómez-Silva M; Gamino Peña ME; Palmer J; Berber A
    Int J Clin Pharmacol Ther; 2015 Oct; 53(10):897-904. PubMed ID: 26308169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of phenytoin sodium capsules available in Thailand. Part II: In vivo study.
    Suthisisang C; Payakachat N; Chulavatnatol S; Towanabut S
    J Med Assoc Thai; 1998 Jan; 81(1):64-70. PubMed ID: 9470324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Single-dose, Comparative Bioavailability Study of a Formulation containing OM3 as Phospholipid and Free Fatty Acid to an Ethyl Ester Formulation in the Fasting and Fed States.
    Lapointe JF; Harvey L; Aziz S; Jordan H; Hegele RA; Lemieux P
    Clin Ther; 2019 Mar; 41(3):426-444. PubMed ID: 30799231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics and gastrointestinal tolerability of a novel extended-release microsphere formulation of azithromycin.
    Chandra R; Liu P; Breen JD; Fisher J; Xie C; LaBadie R; Benner RJ; Benincosa LJ; Sharma A
    Clin Pharmacokinet; 2007; 46(3):247-59. PubMed ID: 17328583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative bioequivalence study of two isotretinoin soft gel capsule formulations in healthy male volunteers.
    Georgarakis M; Zougrou F; Tzavara S; Kontopoulos G; Tsiptsios I
    Int J Clin Pharmacol Ther; 2003 Jul; 41(7):316-22. PubMed ID: 12875348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects.
    Crockett J; Critchley D; Tayo B; Berwaerts J; Morrison G
    Epilepsia; 2020 Feb; 61(2):267-277. PubMed ID: 32012251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the placebo effect modulate drug bioavailability? Randomized cross-over studies of three drugs.
    Hammami MM; Yusuf A; Shire FS; Hussein R; Al-Swayeh R
    J Negat Results Biomed; 2017 May; 16(1):10. PubMed ID: 28535819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of food intake on the pharmacokinetic properties of dalcetrapib: findings from three phase I, single-dose crossover studies in healthy volunteers.
    Derks M; Kawamura H; Abt M; Meneses-Lorente G; Phelan M; Ishikawa T
    Clin Ther; 2011 Jun; 33(6):754-65. PubMed ID: 21704240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic Properties of Ibuprofen (IBU) From the Fixed-Dose Combination IBU/Caffeine (400/100 mg; FDC) in Comparison With 400 mg IBU as Acid or Lysinate Under Fasted and Fed Conditions-Data From 2 Single-Center, Single-Dose, Randomized Crossover Studies in Healthy Volunteers.
    Weiser T; Schepers C; Mück T; Lange R
    Clin Pharmacol Drug Dev; 2019 Aug; 8(6):742-753. PubMed ID: 30897305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a Novel Formulation of Abiraterone Acetate vs. the Originator Formulation in Healthy Male Subjects: Two Randomized, Open-Label, Crossover Studies.
    Goldwater R; Hussaini A; Bosch B; Nemeth P
    Clin Pharmacokinet; 2017 Jul; 56(7):803-813. PubMed ID: 28425029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized Comparative Bioavailability of a Novel Three-Dimensional Printed Fast-Melt Formulation of Levetiracetam Following the Administration of a Single 1000-mg Dose to Healthy Human Volunteers Under Fasting and Fed Conditions.
    Boudriau S; Hanzel C; Massicotte J; Sayegh L; Wang J; Lefebvre M
    Drugs R D; 2016 Jun; 16(2):229-38. PubMed ID: 27028750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.